Infants and the seasonal influenza vaccine: A global perspective on safety, effectiveness, and alternate forms of protection

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 9, 2014, Pages 2721-2728

  Moriarty, Leah F ^a   Omer, Saad B ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cocooning; Maternal antibodies; Maternal immunization; Seasonal influenza; Young infants

Indexed keywords

ALUMINUM PHOSPHATE; AS 03; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; MIFAMURTIDE; PLACEBO; PNEUMOCOCCUS VACCINE; RETINOL; UNCLASSIFIED DRUG; VIROSOME;

ARTICLE; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG SAFETY; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INFANT DISEASE; INFECTION SENSITIVITY; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; JET INJECTOR; NONHUMAN; OTITIS MEDIA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PNEUMOCOCCAL INFECTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL INFLUENZA; SYRINGE; UNSPECIFIED SIDE EFFECT; ADULT; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; INFLUENZA, HUMAN; PREVENTION AND CONTROL; PROCEDURES; VACCINATION;

ADULT; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; VACCINATION;

EID: 84920119890     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29669     Document Type: Article

References (60)

1. Plotkin SO.W.; Offit, P., Vaccines. Vol. 6. 2013, Philadelphia, PA: Elsevier. 1392.
2. Prevention and Control of Influenza with Vaccination: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013, in Morbidity and Mortality Weekly Report, Centers for Disease Control & Prevention. Prevention, Editor. 2013. p. 356.
3. Rimmelzwaan GF, Bodewes R, Osterhaus AD. Vaccination strategies to protect children against seasonal and pandemic influenza. Vaccine 2011; 29:7551-3; PMID:21820479; http://dx.doi.org/10.1016/j.vaccine.2011.08.014
4. Beeler JA, Eichelberger MC. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy. Microb Pathog 2013; 55:9-15; PMID:23247146; http://dx.doi.org/10.1016/j.micpath.2012.11.013
5. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, et al.; Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559-67; PMID:16354892; http://dx.doi.org/10.1056/NEJMoa051721
6. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, et al.; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31-40; PMID:16822994; http://dx.doi.org/10.1056/NEJMoa054869
7. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Simmerman JM, Gordon A, Sato M, Howie S, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011; 378:1917-30; PMID:22078723; http://dx.doi.org/10.1016/S0140-6736(11)61051-9
8. Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 2011; 18:469-76; PMID:21209157; http://dx.doi.org/10.1128/CVI.00396-10
9. Influenza Vaccination. Health Topics 2012; Available from: http://ecdc.europa.eu/en/healthtopics/seasonal-influenza/vaccines/pages/influenza-vaccination.aspx.
10. World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012; 87:461-76; PMID:23210147
11. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26(Suppl 4):D17-22; PMID:19230153; http://dx.doi.org/10.1016/j.vaccine.2008.07.048
12. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
13. Groothuis JRL, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87:823-8; PMID:2034485
14. Halasa NB, Gerber MA, Chen Q, Wright PF, Edwards KM. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008; 197:1448-54; PMID:18444800; http://dx.doi.org/10.1086/587643
15. National Institute for Allergy and Infectious Diseases. Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age [cited 2014 March 16]; NCT00231920]. Available from: http://clinicaltrials.gov/ct2/show/NCT00231920?term=influenza%2C+infants&rank=11.
16. Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC28 Study Team. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J 2010; 29:105-10; PMID:19934787; http://dx.doi.org/10.1097/INF.0b013e3181b84c34
17. Seattle Children's Hospital. Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age (GRC28). [cited 2014 March 16]; NCT00242424]. Available from: http://clinicaltrials.gov/ct2/show/NCT00242424?term=influenza%2C+infants&rank=23.
18. Sanofi Pasteur, a Sanofi Company. Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age [cited 2014 March 16]; NCT00858468]. Available from: http://clinicaltrials.gov/ct2/show/NCT00858468?term=%3C6+months&cond=influenza&intr=vaccine&age=0&rank=10.
19. Gruber WC, Belshe RB, King JC, Treanor JJ, Piedra PA, Wright PF, Reed GW, Anderson E, Newman F. Evaluation of Live Attenuated Influenza Vaccines in Children 6-Months of Age: Safety, Immunogenicity, and Efficacy. J Infect Dis 1996; 173:1313-9; PMID:8648202; http://dx.doi.org/10.1093/infdis/173.6.1313
20. Kendal AP. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur J Epidemiol 1997; 13:591-609; PMID:9258574; http://dx.doi.org/10.1023/A:1007327505862
21. Vaccine Solutions PATH. Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine [cited 2014 March 16]; NCT01625689]. Available from: http://clinicaltrials.gov/ct2/show/NCT01625689?term=bangladesh+influenza&rank=4.
22. International Centre for Diarrheal Disease Research. Bangladesh. A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh. [cited 2014 March 16]; NCT01797029]. Available from: http://clinicaltrials.gov/ct2/show/NCT01797029?term=bangladesh+influenza&rank=2.
23. Karron RA, Steinhoff MC, Subbarao EK, Wilson MH, Macleod K, Clements ML, Fries LF, Murphy BR. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. Pediatr Infect Dis J 1995; 14:10-6; PMID:7715982; http://dx.doi.org/10.1097/00006454-199501000-00002
24. Gruber WC, Darden PM, Still JG, Lohr J, Reed G, Wright PF. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine 1997; 15:1379-84; PMID:9302748; http://dx.doi.org/10.1016/S0264-410X(97)00032-7
25. Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y; Evan-Or. Adjuvanted influenza vaccines. Expert Rev Vaccines 2013; 12:1095-108; PMID:24053401; http://dx.doi.org/10.1586/14760584.2013.825445
26. Banzhoff A, Stoddard JJ. Effective influenza vaccines for children: a critical unmet medical need and a public health priority. Hum Vaccin Immunother 2012; 8:398-402; PMID:22327501; http://dx.doi.org/10.4161/hv.18561
27. Vesikari T, Knuf M, Wutzler P, Karvonen A, Kie-ninger-Baum D, Schmitt HJ, Baehner F, Borkowski A, Tsai TF, Clemens R. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365:1406-16; PMID:21995388; http://dx.doi.org/10.1056/NEJMoa1010331
28. Vaccines N. Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects [cited 2014 March 16]; NCT01342796]. Available from: http://clinicaltrials.gov/ct2/show/NCT01342796?term=%3C6+months&cond=influenza&intr=vaccine&age=0&rank=119.
29. Withdrawal Assessment Report: Fluad Paediatric European Medicines Agency: London, United Kingdom.
30. Wutzler P, Hardt R, Knuf M, Wahle K. Targeted vaccine selection in influenza vaccination. Dtsch Arztebl Int 2013; 110:793-8; PMID:24314622
31. Offit PAJ, Jew RK. Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 2003; 112:1394-7; PMID:14654615; http://dx.doi.org/10.1542/peds.112.6.1394
32. Leroux-Roels I, Vets EF. R.; Seiberling, M.; Weber, F.; Salamand, C.; et a., Seasonal influenza vaccine delivered by intradermal microinjection: A randomized controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614-9; PMID:18930093; http://dx.doi.org/10.1016/j.vaccine.2008.09.078
33. Klein M, Huang N. The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes. J Pediatr 1961; 58:312-4; http://dx.doi.org/10.1016/S0022-3476(61)80260-6; PMID:13756667
34. Chiu SS, Chan KH, Tu W, Lau YL, Peiris JS. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial. Vaccine 2009; 27:4834-9; PMID:19523908; http://dx.doi.org/10.1016/j.vaccine.2009.05.066
35. Parent du Châtelet I, Lang J, Schlumberger M, Vidor E, Soula G, Genet A, Standaert SM, Saliou P; Imule Investigators Group. Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Vaccine 1997; 15:449-58; PMID:9141217; http://dx.doi.org/10.1016/S0264-410X(96)00173-9
36. Centers for Disease Control & Prevention. Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in > = 6 to < 24-month-old Children [cited 2014 March 16]; NCT00386542]. Available from: http://clinicaltrials.gov/ct2/show/NCT00386542?term=influenza%2C+infants&rank=50.
37. McManus M, et al. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 2014; 61:815-20; PMID:24249544
38. High-dose influenza children. [cited 2014 March 16]; Available from: http://clinicaltrials.gov/ct2/results/map?term=high-dose+influenza+children.
39. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993; 168:647-56; PMID:8354906; http://dx.doi.org/10.1093/infdis/168.3.647
40. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-64; PMID:18799552; http://dx.doi.org/10.1056/NEJMoa0708630
41. Steinhoff MC, Omer SB, Roy E, El Arifeen S, Raqib R, Dodd C, Breiman RF, Zaman K. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184:645-53; PMID:22353593; http://dx.doi.org/10.1503/cmaj.110754
42. Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, Ramakrishnan U. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011; 8:e1000441; PMID:21655318; http://dx.doi.org/10.1371/journal.pmed.1000441
43. Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201:547-52; PMID:19850275; http://dx.doi.org/10.1016/j.ajog.2009.09.034
44. Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, Seib K, Breiman RF, Steinhoff MC. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial. J Infect Dis 2013; 207:1144-7; PMID:23300160; http://dx.doi.org/10.1093/infdis/jit003
45. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics 2011; 128:813-25; PMID:21890834; http://dx.doi.org/10.1542/peds.2011-2295
46. Guzman-Cottrill JA, Phillipi CA, Dolan SA, Nyquist AC, Win A, Siegel J. Free vaccine programs to cocoon high-risk infants and children against influenza and pertussis. Am J Infect Control 2012; 40:872-6; PMID:23116758; http://dx.doi.org/10.1016/j.ajic.2012.05.028
47. Duke University. Feasibility of Cocooning Immunization Strategy With Influenza Vaccine (Piiitch) [cited 2014 March 16]; NCT00570037]. Available from: http://clinicaltrials.gov/ct2/show/NCT00570037?term=influenza%2C+infants&rank=93.
48. MaltezouHC, Kalogriopoulou K, Pergialiotis V, Siahanidou T, Skiathitou AV, Katerelos P, Goumalatsos N, Kostis E, Antsaklis A, TheodoridouM. Acceptance of a postpartum influenza vaccination (cocooning) strategy for neonates in Greece. Vaccine 2012; 30:5871-4; PMID:22789503; http://dx.doi.org/10.1016/j.vaccine.2012.06.082
49. Demirjian A, Levy O. Neonatal vaccination: a once in a lifetime opportunity. Pediatr Infect Dis J 2009; 28:833-5; PMID:19710589; http://dx.doi.org/10.1097/INF.0b013e3181badba4
50. Vaccine investment strategy, Background document #2. Influenza 2013 November, 2013; Available from: http://www.gavialliance.org/about/strategy/vaccine-investment-strategy.
51. Influenza Vaccine Strategies for Broad Global Access: Key Findings and Project Methodology, O. Wyman, Editor. 2007, PATH: Seattle, WA.
52. International Centre for Diarrhoeal Disease Research. Bangladesh. Vitamin A and Maternal-infant Flu Vaccine Response. [cited 2014 March 16]; NCT00817661]. Available from: http://clinicaltrials.gov/ct2/show/NCT00817661?term=influenza%2C+infants&rank=3.
53. University of Maryland. Maternal Flu Vaccine Trial in Bamako, Mali [cited 2014 March 16]; NCT01430689]. Available from: http://clinicaltrials.gov/ct2/show/NCT01430689?term=influenza%2C+infants&rank=8.
54. Cincinnati Children's Hospital Medical Center. Field Trial of Maternal Influenza Immunization in Asia (Mothers' Gift) [cited 2014 March 16]; NCT01034254]. Available from: http://clinicaltrials.gov/ct2/show/NCT01034254?term=Mothers+Gift%3A+Asia&rank=1.
55. University of Utah. Maternal Immunization: Giving Immunity For Tomorrow (MI GIFT) January 22, 2013 [cited 2014 March 16]; Available from: http://clinicaltrials.gov/ct2/show/NCT01496079?term=influenza%2C+infants&rank=2.
56. University of Witwatersrand. South Africa. Influenza Vaccine Trial in HIV Uninfected Pregnant Women (Matflu-HIVneg) [cited 2014 March 16]; NCT01306669]. Available from: http://clinicaltrials.gov/ct2/show/NCT01306669?term=influenza%2C+infants&rank=35.
57. National Institute for Allergy and Infectious Diseases. Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post Partum Breast Feeding Women. [cited 2014 March 16]; NCT01181323]. Available from: http://clinicaltrials.gov/ct2/show/NCT01181323?term=influenza%2C+infants&rank=10.
58. Adegbola R, Nesin M, Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012; 207(Suppl):S28-32; PMID:22920055
59. National Institute for Allergy and Infectious Diseases. 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [cited 2014 March 16]; NCT01173211]. Available from: http://clinicaltrials.gov/ct2/show/NCT01173211?term=influenza%2C+infants&rank=168.
60. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006; 28:47-53; PMID:16731574; http://dx.doi.org/10.1093/epirev/mxj002